GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Eli Lilly and Co (XSGO:LLYCL) » Definitions » Sale Of Investment

Eli Lilly and Co (XSGO:LLYCL) Sale Of Investment : CLP491,472 Mil (TTM As of Mar. 2025)


View and export this data going back to 2024. Start your Free Trial

What is Eli Lilly and Co Sale Of Investment?

Eli Lilly and Co's sale of investment for the three months ended in Mar. 2025 was CLP66,755 Mil. It means Eli Lilly and Co gained CLP66,755 Mil from selling investments. Eli Lilly and Co's sale of investment for the trailing twelve months (TTM) ended in Mar. 2025 was CLP491,472 Mil.

Compared with last quarter (CLP95,702 Mil in Dec. 2024 ), Eli Lilly and Co gained less money from selling investments in Mar. 2025 (CLP66,755 Mil).


Eli Lilly and Co Sale Of Investment Historical Data

The historical data trend for Eli Lilly and Co's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eli Lilly and Co Sale Of Investment Chart

Eli Lilly and Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Sale Of Investment
Get a 7-Day Free Trial Premium Member Only Premium Member Only 647,675.73 720,136.54 404,463.41 613,291.86 514,447.41

Eli Lilly and Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Sale Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 68,363.06 236,612.97 92,402.78 95,701.99 66,754.66

Eli Lilly and Co Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was CLP491,472 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Eli Lilly and Co Sale Of Investment Related Terms

Thank you for viewing the detailed overview of Eli Lilly and Co's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.


Eli Lilly and Co Business Description

Address
Lilly Corporate Center, Indianapolis, IN, USA, 46285
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.

Eli Lilly and Co Headlines

No Headlines